In the original article, we neglected to disclose that authors Lisa A. King and Roeland Lameris are currently funded by Lava Therapeutics and that Hans J. van der Vliet also acts as chief scientific officer of Lava Therapeutics. Hans J. van der Vliet's affiliation has been updated to reflect this. The corrected Conflict of Interest statement appears below.
Statements
Conflict of interest
LK and Rl are funded by Lava Therapeutics. HV acts as chief scientific officer of Lava Therapeutics. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
iNKT cells, CD1d, α-GalCer, glycolipids, cancer immunotherapy
Citation
King LA, Lameris R, de Gruijl TD and van der Vliet HJ (2018) Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond. Front. Immunol. 9:2606. doi: 10.3389/fimmu.2018.02606
Received
19 October 2018
Accepted
23 October 2018
Published
20 November 2018
Approved by
Frontiers in Immunology Editorial Office, Frontiers Media SA, Switzerland
Volume
9 - 2018
Updates
Copyright
© 2018 King, Lameris, de Gruijl and van der Vliet.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hans J. van der Vliet jj.vandervliet@vumc.nl
This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.